PMC5351229_01
Exfoliation of skin over the palm in a patient with hydroxychloroquine-induced erythroderma
IJPharm-49-132-g001.jpg
PMC5351229_01_IJPharm-49-132-g001.jpg
F1
Cutaneous examination showed diffuse erythema of skin over the face, upper limb, trunk, and lower limb with exfoliation of the skin [Figures 1 and 2].
Exfoliation of skin over the foot in a patient with hydroxychloroquine-induced erythroderma
IJPharm-49-132-g002.jpg
PMC5351229_01_IJPharm-49-132-g002.jpg
F2
Cutaneous examination showed diffuse erythema of skin over the face, upper limb, trunk, and lower limb with exfoliation of the skin [Figures 1 and 2].
Beau's lines over the fingernail in a patient with hydroxychloroquine-induced erythroderma
IJPharm-49-132-g003.jpg
PMC5351229_01_IJPharm-49-132-g003.jpg
F3
Nail examination showed beau's lines over the finger and toenail [Figure 3].
Microscopic appearance of a biopsy done from the erythematous scaly plaque in a patient with hydroxychloroquine-induced erythroderma. (a and b) Hyperplastic stratified squamous epithelium with mild spongiosis. (c and d) The dermis shows perivascular moderate lymphocytic infiltrate
IJPharm-49-132-g005.jpg
PMC5351229_01_IJPharm-49-132-g005.jpg
F4
Focal areas of neutrophilic inflammatory infiltrate admixed with parakeratosis were also present which confirmed erythroderma [Figure 4].